PRODUCT NAME:
Product Name: Valproic Acid CLIA Kit (Chemiluminescence Immunoassay)
Abbreviation: VPA
INTENDED USE:
Valproic Acid CLIA Kit (Chemiluminescence Immunoassay) is an in vitro diagnostic test for the quantitative detection
of Valproic Acid (VPA) in human serum and plasma specimen. This product is intended to be used by laboratory
professional workers only. This kit is used for auxiliary diagnosis. Results must be combined with clinical
observations, patient history, other laboratory parameters, and epidemiological information.
Valproic acid is a recognized broad-spectrum antiepileptic drug, which is mainly used to treat various types of
epileptic seizures, including generalized tonic-clonic seizures, myoclonic seizures, and petit mal. In addition, valproic
acid can also be used for a variety of psychiatric and neurological diseases, such as bipolar neuronal disorder,
schizophrenia, depression, neuralgia, migraine, Alzheimer's disease and other neurological disorders. It is a
broad-spectrum drug and first-line drug for the clinical treatment of epilepsy. It is frequently used in clinical
application. However, due to the large differences in the pharmacokinetics and pharmacodynamics of different
individuals, the dosage of valproic acid is difficult to control. In order to exert the curative effect and reduce the
adverse reactions, during the clinical application of valproic acid to treat epilepsy, it is necessary to monitor the
therapeutic drug blood concentration.